School of Medicine
Showing 9,721-9,740 of 13,040 Results
-
Richard Roth
Professor of Chemical and Systems Biology, Emeritus
Current Research and Scholarly InterestsInsulin is one of the primary regulators of rapid anabolic responses in the body. Defects in the synthesis and/or ability of cells to respond to insulin results in the condition known as diabetes mellitus. To better design methods of treatment for this disorder, we have been focusing our research on how insulin elicits its various biological responses.
-
Stephen J. Roth
Professor of Pediatrics (Cardiology), Emeritus
Current Research and Scholarly InterestsRandomized Therapeutic Trials in Pediatric Heart Disease, NIH/U01 GrantNo. HL68285 2001-2006.
Heparin and the Reduction of Thrombosis (HART) Study. Pediatric Health Research Fund Award, Stanford Univ Sch of Medicine, 2005-2006.
A Pilot Trial fo B-type Natriuretic Peptide for Promotion of Urine Output in Diuretic-Resistant Infants Following Cardiovascular Surgery.Pediatric Health Research Fund Award, Stanford Univ Sch of Medicine, 2005-2006. -
Theodore Roth
Assistant Professor of Pathology
Current Research and Scholarly InterestsThe Roth Lab develops, applies, and translates scalable genetic manipulation technologies in primary human cells and complex in vivo tissue environments. Working with students, trainees, and staff with backgrounds across bioengineering, genetics, immunology, oncology, and pathology, the lab has developed CRISPR-All, a unified genetic perturbation language able to arbitrarily and combinatorially examine genetic perturbations across perturbation type and scale in primary human cells. Ongoing applications of CRISPR-All in the lab have revealed surprising capacities to synthetically engineer human cells beyond evolved cellular states. These new capacities to perturb human cell’s genetics beyond their evolved functionality drives ongoing work to understand the biology and therapeutic potential of synthetic cell state engineering - in essence learning how to build new human genes tailor made for a specific cell and specific environment to drive previously inaccessible therapeutic cellular functions.
-
Walton T. Roth
Professor of Psychiatry & Behavioral Sciences, Emeritus
Current Research and Scholarly InterestsLaboratory and ambulatory recording of physiological, responses to stressors in anxious and phobic patients.
-
Raheleh Roudi
Life Science Research Professional 2, Pediatrics - Hematology/Oncology
BioRaheleh Roudi is a research scientist in the Department of Radiology at Stanford University. Dr. Roudi trained at the Iran University of Medical Sciences, Iran. She worked as an Assistant Professor at the Iran University of Medical Sciences, Iran from 2015 to 2019, before coming to the United States. During this time, Dr. Roudi worked on several projects which have led to successful collaborations with the Karolinska Institute; Charite Universitatsmedizin Berlin; Oslo University Hospital; National University of Singapore; Shanghai University of Traditional Chinese Medicine and University of Brescia, among other internationally recognized institutions.
Dr. Roudi was a visiting scientist in the University of Texas at San Antonio and then appointed as a postdoctoral associate at the University of Minnesota for one year, before joining Stanford University in 2022.
Her research interest focuses on the molecular oncology and immunotherapies of solid tumors and she published more than 40 peer reviewed papers. -
Dara Rouholiman
Affiliate,
BioDara Rouholiman is a machine learning research engineer at Stanford AIM Lab, where he develops and evaluates predictive and generative models for anesthesia and perioperative medicine. His current research focuses on LLM evaluation in clinical settings, deep learning for time-series forecasting, and ML-driven perioperative risk prediction using electronic health records.
His work on tool-augmented LLMs for clinical calculations was published in Nature's npj Digital Medicine (2025). Previously, he led ML development at COR, an at-home blood-monitoring device startup (3 patents filed), and co-founded Telesphora, whose opioid overdose prediction model was deployed with the Connecticut Department of Public Health. He holds a B.S. in physical chemistry from UC Santa Cruz and serves as Lead Instructor for Stanford SASI's Healthcare Innovation Internship. -
Larissa Roux MD PhD
Adjunct Professor, Medicine - Primary Care and Population Health
BioLarissa Roux is a sport medicine physician and health economist. She completed medical school at the University of Alberta, and followed this with residency training in family medicine and a fellowship in primary care sport medicine at the University of Calgary, as well as advanced training in lifestyle medicine. She combined her clinical training with a master’s in public health at Harvard, and a PhD in health economics at the University of Calgary. Her interest in public health and health policy resulted in a post-doctoral fellowship at the US Centers for Disease Control, in Atlanta in the Division of Nutrition and Physical Activity. Although she has deeply enjoyed working with athletes and dancers, her main clinical interest has been in the optimization of human performance in patients with chronic conditions, including obesity, arthritis, and trauma. Her academic and health policy work has focused on the economic evaluation of competing therapies for obesity, and population-level physical activity promotion strategies in the US and around the world. Larissa's interest in data science and technology applications in global health contributed to an ongoing health information technology venture. She believes that innovative, tailored, multidisciplinary, and multimodal approaches to chronic disease have transformative potential in human health.
-
Corey Rovzar
Instructor, Medicine - Stanford Prevention Research Center
Current Research and Scholarly InterestsEnhancing human movement through scalable, remotely delivered physical activity interventions, remote assessment and monitoring of human movement, health technology development, fall prevention, aging, digital balance assessment, improving access to health and healthcare, increasing healthspan, lifestyle medicine
